Patents by Inventor Anh Tran

Anh Tran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200385357
    Abstract: Cyclohexane derivatives of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor.
    Type: Application
    Filed: August 25, 2020
    Publication date: December 10, 2020
    Inventors: Thuy-Anh TRAN, Rena HAYASHI, Jason B. IBARRA, Brett ULLMAN, Ning ZOU
  • Publication number: 20200385395
    Abstract: The present invention relates to compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the beta-3 adrenergic receptor.
    Type: Application
    Filed: December 6, 2018
    Publication date: December 10, 2020
    Inventors: Thuy-Anh Tran, Brett Ullman, Bryan Aubrey Kramer, Quyen-Quyen Thuy Do, Young-Jun Shin
  • Publication number: 20200375930
    Abstract: The present invention relates to amide derivatives of Formula (XIIIa) and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor.
    Type: Application
    Filed: April 14, 2020
    Publication date: December 3, 2020
    Inventors: Thuy-Anh TRAN, Weichao CHEN, Bryan A. KRAMER, Abu J.M. SADEQUE, Anna SHIFRINA, Young-Jun SHIN, Pureza VALLAR, Ning ZOU
  • Patent number: 10833681
    Abstract: This disclosure relates to a receiver comprising a clock and data recovery loop and a phase offset loop. The clock and data recovery loop may be controlled by a sum of gradients for a plurality of data interleaves. The phase offset loop may be controlled by an accumulated differential gradient for each of the data interleaves.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: November 10, 2020
    Assignee: NVIDIA Corp.
    Inventors: Gaurawa Kumar, Ky-Anh Tran, Olakanmi Oluwole, Vishnu Balan
  • Patent number: 10804323
    Abstract: Memory devices and manufacturing methods thereof are presented. A memory device a substrate and a memory cell having at least one selector and a storage element. The selector includes a well of a first polarity type disposed in the substrate, a region of a second polarity type disposed over the well and in the substrate, and first and second regions of the first polarity type disposed adjacent to the region of the second polarity type. The storage element includes a programmable resistive layer disposed on the region of the second polarity type and an electrode disposed over the programmable resistive layer.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: October 13, 2020
    Assignee: GLOBALFOUNDRIES SINGAPORE PTE. LTD.
    Inventors: Xuan Anh Tran, Eng Huat Toh, Shyue Seng Tan, Yuan Sun, Elgin Kiok Boone Quek
  • Patent number: 10793753
    Abstract: A process for increasing MFR2 of a polyethylene copolymer or an ethylene plastomer or elastomer comprising: (I) extruding a copolymer of polyethylene copolymer having a density of 910 to 970 kg/m3 and an MFR2 of 1 and 100 g/10 min or an ethylene plastomer or elastomer having a density of 855 to 910 kg/m3 and an MFR2 of 0.5 and 100 g/10 min in the presence of 0.1 to 2 wt % of a non-peroxide radical initiator so as to produce a polyethylene copolymer having an MFR2 of 200 g/10 min or more, or an ethylene plastomer or elastomer having a MFR2 of 200 g/10 min or more.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: October 6, 2020
    Assignee: BOREALIS AG
    Inventors: Tuan Anh Tran, Marc Knaepen
  • Patent number: 10793529
    Abstract: Cyclohexane derivatives of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor.
    Type: Grant
    Filed: October 15, 2018
    Date of Patent: October 6, 2020
    Assignee: ARENA PHARMACEUTICALS, INC.
    Inventors: Thuy-Anh Tran, Rena Hayashi, Jason B. Ibarra, Brett Ullman, Ning Zou
  • Publication number: 20200270264
    Abstract: The present invention relates to compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the beta-3 adrenergic receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of a beta-3 adrenergic receptor-mediated disorder, such as, heart failure; cardiac performance in heart failure; mortality, reinfarction, and/or hospitalization in connection with heart failure; acute heart failure; acute decompensated heart failure; congestive heart failure; severe congestive heart failure; organ damage associated with heart failure (e.g.
    Type: Application
    Filed: May 12, 2020
    Publication date: August 27, 2020
    Inventors: Thuy-Anh Tran, Quyen-Quyen Do, Brett Ullman, Anthony C. Blackburn, Maiko Nagura
  • Publication number: 20200247755
    Abstract: The present invention pertains to certain compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT2A serotonin receptor. Compounds and pharmaceutical compositions thereof are directed to methods useful in the treatment of platelet aggreagation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, blood clot formation, asthma or symptoms thereof, agitation or a symptom thereof, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorder, psychosis, acute schizophrenia, chronic schizophrenia, NOS schizophrenia and related disorders, and sleep disorders, sleep disorders, diabetic-related disorders, progressive multifocal leukoencephalopathy and the like.
    Type: Application
    Filed: September 11, 2019
    Publication date: August 6, 2020
    Inventors: Bradley Teegarden, Dennis Chapman, Marc Decaire, Peter I. Dosa, Konrad Feichtinger, Honnappa Jayakumar, Thuy-Anh Tran, Sonja Strah-Pleynet, Jay Xu
  • Publication number: 20200227424
    Abstract: One illustrative MPT device disclosed herein includes an active region and an inactive region, isolation material positioned between the active region and the inactive region, the isolation material electrically isolating the active region from the inactive region, and an FG MTP cell formed in the active region. In this example, the FG MTP cell includes a floating gate, wherein first, second and third portions of the floating gate are positioned above the active region, the inactive region and the isolation material, respectively, and a control gate positioned above at least a portion of the inactive region, wherein the control gate is positioned above an upper surface and adjacent opposing sidewall surfaces of at least a part of the second portion of the floating gate.
    Type: Application
    Filed: January 14, 2019
    Publication date: July 16, 2020
    Inventors: Xuan Anh Tran, Sunil Kumar Singh, Shyue Seng Tan
  • Patent number: 10689372
    Abstract: Pyrazole derivatives of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: June 23, 2020
    Assignee: ARENA PHARMACEUTICALS, INC.
    Inventors: Thuy-Anh Tran, Jason B. Ibarra, Young-Jun Shin, Brett Ullman, Ning Zou, Xi Zeng
  • Patent number: 10668033
    Abstract: The present invention relates to amide derivatives of Formula (XIIIa) and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: June 2, 2020
    Assignee: ARENA PHARMACEUTICALS, INC.
    Inventors: Thuy-Anh Tran, Weichao Chen, Bryan A. Kramer, Abu J. M. Sadeque, Anna Shifrina, Young-Jun Shin, Pureza Vallar, Ning Zou
  • Patent number: 10662200
    Abstract: The present invention relates to compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the beta-3 adrenergic receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of a beta-3 adrenergic receptor-mediated disorder, such as, heart failure; cardiac performance in heart failure; mortality, reinfarction, and/or hospitalization in connection with heart failure; acute heart failure; acute decompensated heart failure; congestive heart failure; severe congestive heart failure; organ damage associated with heart failure (e.g.
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: May 26, 2020
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Thuy-Anh Tran, Quyen-Quyen Do, Brett Ullman, Anthony C. Blackburn, Maiko Nagura
  • Patent number: 10651238
    Abstract: Multi-time programmable (MTP) random access memory (RRAM) devices and methods for forming a MTP RRAM device are disclosed. The method includes providing a substrate. The substrate is prepared with at least a first region for accommodating one or more multi-programmable based resistive random access memory (RRAM) cell. A fin-type based selector is provided over the substrate in the first region. A storage element of the RRAM cell is formed over the fin-type based selector. The fin-type based selector is coupled in series with the storage element of the RRAM cell.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: May 12, 2020
    Assignee: GLOBALFOUNDRIES SINGAPORE PTE. LTD.
    Inventors: Xuan Anh Tran, Eng Huat Toh
  • Publication number: 20200055798
    Abstract: A method for producing an ?-olefin oligomer, the method including subjecting ?-olefin to oligomerization reaction to produce an ?-olefin oligomer mixture, carrying out distillation separation of ?-olefin oligomer having less than n carbon atoms in the mixture to obtain a distillation residue containing ?-olefin oligomer having n or more carbon atoms, and then carrying out a step of removing high molecular weight molecules from the distillation residue.
    Type: Application
    Filed: November 15, 2017
    Publication date: February 20, 2020
    Applicant: IDEMITSU KOSAN CO., LTD.
    Inventors: Shinji MIYAMOTO, Naoya KAWANO, Tuan Anh TRAN
  • Publication number: 20190389875
    Abstract: The present invention relates to compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the beta-3 adrenergic receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of a beta-3 adrenergic receptor-mediated disorder, such as, heart failure; cardiac performance in heart failure; mortality, reinfarction, and/or hospitalization in connection with heart failure; acute heart failure; acute decompensated heart failure; congestive heart failure; severe congestive heart failure; organ damage associated with heart failure (e.g.
    Type: Application
    Filed: September 6, 2019
    Publication date: December 26, 2019
    Inventors: Thuy-Anh Tran, Quyen-Quyen Do, Brett Ullman, Anthony C. Blackburn, Maiko Nagura
  • Patent number: 10488995
    Abstract: A method of detecting a user input includes sensing one or more touch events at a device. In some embodiments, a method includes sensing a first touch event via a first housing of a device. The method also includes generating a first detection signal based on the first touch event. The method also includes sensing a second touch event via a second housing of the device, the second housing conductively isolated from the first housing. The method also includes generating a second detection signal based on the second touch event. The method also includes classifying, based on the first detection signal and the second detection signal, the first touch event as user input. The method also includes identifying one or more actions based on the classification of the first touch event as the user input, the one or more actions associated with the user input.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: November 26, 2019
    Assignee: Google LLC
    Inventors: Neraj Paul Bobra, Timothy Golnik, Tuan-Anh Tran, Adam Mekeel Mack, Steven Diamond, Matthew Ryan Montgomery
  • Patent number: 10479797
    Abstract: The present invention relates to compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the beta-3 adrenergic receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of a beta-3 adrenergic receptor-mediated disorder, such as, heart failure; cardiac performance in heart failure; mortality, reinfarction, and/or hospitalization in connection with heart failure; acute heart failure; acute decompensated heart failure; congestive heart failure; severe congestive heart failure; organ damage associated with heart failure (e.g.
    Type: Grant
    Filed: June 4, 2019
    Date of Patent: November 19, 2019
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Thuy-Anh Tran, Quyen-Quyen Do, Brett Ullman, Anthony C. Blackburn, Maiko Nagura
  • Patent number: 10461173
    Abstract: A method, apparatus, and manufacturing system are disclosed herein for a vertical field effect transistor (vFET) including top and bottom source/drain regions produced in one epitaxial growth process. The vFET may contain a semiconductor substrate; a fin above the semiconductor substrate; a structure on a middle portion of each sidewall of the fin, wherein a lower portion of each sidewall of the fin adjacent the semiconductor substrate and at least a top of the fin are uncovered by the structure; a top source/drain (S/D) region on at least the top of the fin; and a bottom S/D region on the lower portion of the fin and the semiconductor substrate. The structure on each sidewall may be a gate or a dummy gate, i.e., the vFET may be formed in a gate-first or a gate-last process.
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: October 29, 2019
    Assignee: GLOBALFOUNDRIES INC.
    Inventors: Ajey Poovannummoottil Jacob, Xuan Anh Tran, Hui Zang, Bala Haran, Suryanarayana Kalaga
  • Patent number: 10450276
    Abstract: The present invention pertains to certain compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT2A serotonin receptor. Compounds and pharmaceutical compositions thereof are directed to methods useful in the treatment of platelet aggreagation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, blood clot formation, asthma or symptoms thereof, agitation or a symptom thereof, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorder, psychosis, acute schizophrenia, chronic schizophrenia, NOS schizophrenia and related disorders, and sleep disorders, sleep disorders, diabetic-related disorders, progressive multifocal leukoencephalopathy and the like.
    Type: Grant
    Filed: August 22, 2016
    Date of Patent: October 22, 2019
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Bradley Teegarden, Dennis Chapman, Marc Decaire, Peter I. Dosa, Konrad Feichtinger, Honnappa Jayakumar, Thuy-Anh Tran, Sonja Strah-Pleynet, Jay Xu